Details for New Drug Application (NDA): 011950
✉ Email this page to a colleague
NDA 011950 describes TACARYL, which is a drug marketed by Westwood Squibb and is included in one NDA. Additional details are available on the TACARYL profile page.
The generic ingredient in TACARYL is methdilazine. There are four drug master file entries for this compound. Additional details are available on the methdilazine profile page.
The generic ingredient in TACARYL is methdilazine. There are four drug master file entries for this compound. Additional details are available on the methdilazine profile page.
Summary for 011950
| Tradename: | TACARYL |
| Applicant: | Westwood Squibb |
| Ingredient: | methdilazine |
| Patents: | 0 |
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 8MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 4MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 009
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 3.6MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
